• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is China Everbright (SEHK:165) Fully Valued Following Its FTSE All World Index Removal?

    Simply Wall St·09/28/2026 23:23:28
    語音播報

    China Everbright (SEHK:165) has been removed from the FTSE All-World Index (USD), a move that can trigger selling by funds that closely mirror the benchmark and rely on its constituents.

    Recent trading shows a mixed picture for China Everbright. The share price has climbed 23.9% over the past 90 days and gained 5.3% in the last session to HK$6.455. However, the year-to-date share price return is down 32.05% and the 1-year total shareholder return has declined 45.25%, while the 3-year total shareholder return is up 52.45%. This points to stronger longer-term momentum than the recent headline losses suggest.

    Scan how other financials are reacting to similar index changes and where fresh momentum might be building by reviewing the 618 high quality undiscovered gems alongside China Everbright today.

    So has the recent index exit already flushed out most of the sellers in China Everbright, or is the recent rebound pricing in the bulk of the upside before the valuation case even starts?

    Preferred Price-to-Sales of 13.1x: Is It Justified for China Everbright?

    Valuation for China Everbright currently leans heavily on its Price-to-Sales ratio, which sits at 13.1x on the latest figures. That multiple is sitting well above both peer and industry references, so anyone looking at the recent price rebound needs to keep this context in mind.

    P/S compares the company’s market value to its revenue and is often used for financial groups where earnings are volatile or currently in loss. For China Everbright, this lens matters because the business is unprofitable and reported a loss of HK$4,467.09m on revenue of HK$828.56m. As a result, traditional earnings-based multiples like P/E are not meaningful right now.

    The current P/S of 13.1x is described as expensive relative to both its direct peers at 6.7x and the wider Hong Kong Capital Markets industry at 3.1x. That is a very wide gap, and the fair Price-to-Sales estimate of 1.3x suggests a level the market could move towards if sentiment or growth expectations adjust over time.

    Explore the SWS fair ratio for China Everbright.

    Result: Price-to-Sales of 13.1x (OVERVALUED)

    Still, China Everbright faces clear risks if the current loss of HK$4,467.09m persists or if investor attention shifts away from higher P/S financial groups.

    Find out about the key risks to this China Everbright narrative.

    Next Steps

    Mixed signals around China Everbright can be confusing. Check the numbers yourself, weigh the current concerns against the potential upside, and review the 1 key reward and 1 important warning sign.

    Want more ideas beyond China Everbright?

    If China Everbright has you rethinking where the next opportunity might come from, now is the time to widen your search before the crowd catches on.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.